Annales De Dermatologie Et De Venereologie最新文献_第10页

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases 皮下泛膜炎样t细胞淋巴瘤表现为面部浸润，甲氨蝶呤长期有效:2例

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.04.003

D. Marcé , D. Canu , C. Laurent , C. Pottier , M.-L. Jullie , T. Kervarrec , M. Beylot-Barry , M. Samimi

引用次数: 0

Omalizumab-induced paradoxical urticaria responsive to dupilumab omalizumab诱导的对dupilumab应答的矛盾荨麻疹

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.007

A.-C. Fougerousse, A. Badaoui

引用次数: 0

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer 阿扑胺治疗前列腺癌症后罕见且严重的地衣样皮肤出疹。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.09.001

P.-F. Guglielmini, C. Massone, C. Grasso, A. Francese, M. Vincenti, S. Chiodi, M. Rossi, A. Maconi

引用次数: 0

Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec 蕈样肉芽肿和Sézary综合征的临床特征、初步治疗和预后：魁北克大学医院中心的一项回顾性单中心研究。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.006

M. Lachance, M.-M. Thibeault

引用次数: 0

A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin 面部血管纤维瘤伴结节性硬化症患者的调查：局部雷帕霉素的短期、中期和长期疗效和安全性。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.009

N. Sigg , J. Fouquet , D. Morin , D. Farges , S. Vrignaud , L. Martin

{"title":"A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin","authors":"N. Sigg , J. Fouquet , D. Morin , D. Farges , S. Vrignaud , L. Martin","doi":"10.1016/j.annder.2023.06.009","DOIUrl":"10.1016/j.annder.2023.06.009","url":null,"abstract":"<div><h3>Aims</h3><p><span>Topical rapamycin<span> is used to reduce facial angiofibromas<span> in patients with </span></span></span>tuberous sclerosis (TSC). In the absence of a commercially available preparation, numerous formulations have been tested clinically, although only in the short term.</p></div><div><h3>Methods</h3><p>The pharmacy at Angers University Hospital (France) produced a cream formulation that was administered to people presenting this genetic disease. We conducted a questionnaire-based survey among 79 patients with TSC about their perceptions regarding the short-, medium- and long-term efficacy and safety of a topical rapamycin preparation in relation to facial angiofibromas.</p></div><div><h3>Results</h3><p>This formulation was very well tolerated and its efficacy was sustained over the long term with a mean treatment duration of 33 months (extremes 1–60). Efficacy was rated ≥ 8/10 by 67.1% of patients while safety was rated ≥ 8/10 by 84.8% of patients.</p></div><div><h3>Conclusion</h3><p>This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.</p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 270-273"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41188901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cutaneous pseudolymphoma following sub-cutaneous immunotherapy for dust mites 皮肤假性淋巴瘤后皮下免疫治疗尘螨。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.09.002

A. Badaoui, I. Moulonguet

引用次数: 0

The carbon footprint of dermatologists: Time for a change? 皮肤科医生的碳足迹:是时候改变了?

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.10.001

Nicolas Kluger

引用次数: 0

Self-induced nail disorders (SINDs): What do we know so far? 自我引发的指甲疾病：到目前为止我们知道什么？

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.05.005

M. Starace , S. Cedirian , A. Alessandrini , F. Bruni , B.M. Piraccini , M. Iorizzo

引用次数: 0

Evaluation of parents’ knowledge following a sun-protection campaign in schools in La Reunion 留尼汪学校开展防晒运动后对家长知识的评估。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.03.012

N. Breton, L. Bruneau, J. Dumez, J. Miquel, F. Villeroy, M. Beylot-Barry, N. Sultan-Bichat, A. Bertolotti

引用次数: 0

Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners 尼沃单抗诱导的嗜酸性筋膜炎：一种不寻常的免疫相关不良事件，需要从业者认识。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.07.001

M. Benzaquen, L. Christ, N. Sutter, B.C. Özdemir

引用次数: 0